Share this Page:
This review, published in HemOnc Today this week, discusses the various combination treatments available and in development for advanced/metastatic renal cell carcinoma (RCC) with world-leading experts in the management of kidney cancer. The review states that “Developing treatments that induce disease remission and eventually lead to cure is the highest priority for these patients.”
